Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Mark Bustoros, MD, Dana-Farber Cancer Institute, Boston, MA, interviews with VJHemOnc at the International Myeloma Workshop (IMW) 2019, held in Boston, MA, and discusses how the genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.